General Information of the Molecule (ID: Mol01099)
Name
Tethering factor for nuclear proteasome STS1 (STS1) ,Saccharomyces cerevisiae
Synonyms
Dumbbell former protein 8; SEC23 suppressor 1; DBF8; SSM5; YIR011C; YIB11C
    Click to Show/Hide
Molecule Type
Protein
Gene Name
STS1
Gene ID
854828
Sequence
MMGFEWGFKPSSKITQSTVSSQGTGNVMIPTAGVKQKRRYANEEQEEEELPRNKNVMKYG
GVSKRRPQPGSLIRGQPLPLQRGMELMNKNQLQQLLVDLMTKHPEIQQSVHTRVIGLDFS
IQKCLDMLKQKSEAVYQSIPYNRSYESNKLDDYAFVRMKPQILEFLNCLVDFILDNIPPR
LENLHASLKFLDICTELVIKLPRFELASNNYYYDKCIEQLSHVWCTLIEHVARDRIILLA
DNSSVWKSHMTRLQVYNEHSNGLLERPLQLFKSLDMGSPSAASSSTLSLQESIIYHHDTM
TANENNNNSGSAATDSPFN
    Click to Show/Hide
Function
Involved in ubiquitin-mediated protein degradation. Regulatory factor in the ubiquitin/proteasome pathway that controls the turnover of proteasome substrates. Targets proteasomes to the nucleus and facilitates the degradation of nuclear proteins. Required for efficient chromosome segregation. Restores protein transport and ribosomal RNA stability.
    Click to Show/Hide
Uniprot ID
STS1_YEAST
        Click to Show/Hide the Complete Species Lineage
Kingdom: Fungi
Phylum: Ascomycota
Class: Saccharomycetes
Order: Saccharomycetales
Family: Saccharomycetaceae
Genus: Saccharomyces
Species: Saccharomyces cerevisiae
Type(s) of Resistant Mechanism of This Molecule
  UAPP: Unusual Activation of Pro-survival Pathway
Drug Resistance Data Categorized by Drug
Approved Drug(s)
3 drug(s) in total
Click to Show/Hide the Full List of Drugs
Fluconazole
Click to Show/Hide
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms
       Unusual Activation of Pro-survival Pathway (UAPP) Click to Show/Hide
Disease Class: Recurrent oropharyngeal candidiasis [1]
Sensitive Disease Recurrent oropharyngeal candidiasis [ICD-11: 1F23.6]
Sensitive Drug Fluconazole
Molecule Alteration Deletion mutation
Deleteion
Experimental Note Identified from the Human Clinical Data
In Vitro Model Saccharomyces cerevisiae strain 4932
Experiment for
Molecule Alteration
qPCR; TEF3 probe assay
Experiment for
Drug Resistance
Microbroth dilution MIC assay
Mechanism Description The S. cerevisiae sts1 deletion mutant was hypersusceptible to all three azole derivatives used in the study, which is a strong indication that Sts1, a close homolog of Cdr1, is implicated in their transport.
Itraconazole
Click to Show/Hide
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms
       Unusual Activation of Pro-survival Pathway (UAPP) Click to Show/Hide
Disease Class: Recurrent oropharyngeal candidiasis [1]
Sensitive Disease Recurrent oropharyngeal candidiasis [ICD-11: 1F23.6]
Sensitive Drug Itraconazole
Molecule Alteration Deletion mutation
Deleteion
Experimental Note Identified from the Human Clinical Data
In Vitro Model Saccharomyces cerevisiae strain 4932
Experiment for
Molecule Alteration
qPCR; TEF3 probe assay
Experiment for
Drug Resistance
Microbroth dilution MIC assay
Mechanism Description The S. cerevisiae sts1 deletion mutant was hypersusceptible to all three azole derivatives used in the study, which is a strong indication that Sts1, a close homolog of Cdr1, is implicated in their transport.
Ketoconazole
Click to Show/Hide
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms
       Unusual Activation of Pro-survival Pathway (UAPP) Click to Show/Hide
Disease Class: Recurrent oropharyngeal candidiasis [1]
Sensitive Disease Recurrent oropharyngeal candidiasis [ICD-11: 1F23.6]
Sensitive Drug Ketoconazole
Molecule Alteration Deletion mutation
Deleteion
Experimental Note Identified from the Human Clinical Data
In Vitro Model Saccharomyces cerevisiae strain 4932
Experiment for
Molecule Alteration
qPCR; TEF3 probe assay
Experiment for
Drug Resistance
Microbroth dilution MIC assay
Mechanism Description The S. cerevisiae sts1 deletion mutant was hypersusceptible to all three azole derivatives used in the study, which is a strong indication that Sts1, a close homolog of Cdr1, is implicated in their transport.
References
Ref 1 Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother. 1995 Nov;39(11):2378-86. doi: 10.1128/AAC.39.11.2378.

If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.